Mutual of America Capital Management LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 126,220 shares of the company's stock after selling 3,899 shares during the period. Mutual of America Capital Management LLC's holdings in Colgate-Palmolive were worth $11,475,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also made changes to their positions in the company. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the 4th quarter worth $32,000. Bernard Wealth Management Corp. bought a new position in shares of Colgate-Palmolive during the 4th quarter worth about $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the third quarter valued at about $42,000. Finally, Roxbury Financial LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth about $43,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts have commented on CL shares. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday. TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. Royal Bank of Canada reiterated a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Raymond James restated an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and a consensus target price of $101.61.
Read Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Up 0.9 %
CL stock traded up $0.81 during mid-day trading on Wednesday, hitting $91.87. 3,446,465 shares of the company were exchanged, compared to its average volume of 4,103,554. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm has a market cap of $74.56 billion, a P/E ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The firm's 50 day simple moving average is $88.72 and its 200 day simple moving average is $95.27. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company posted $0.87 earnings per share. On average, sell-side analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.18%. Colgate-Palmolive's payout ratio is 56.82%.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.